Business
PURE Bioscience Sets Q3 Results Conference Call to Review Progress of SDC-Based Antimicrobial Food Safety Solutions Strategy
PURE Bioscience Sets Q3 Results Conference Call to Review Progress of SDC-Based Antimicrobial Food Safety Solutions Strategy.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) \n antimicrobial, announced today that the Company will publish fiscal Q3 \n financial results shortly after the market closes, and host an investor \n conference call on Thursday, June 8, 2017 at 1:30pm PDT (4:30pm EDT).\n \n \n In addition to discussion of third fiscal quarter and nine-month 2017 \n results, PURE’s management will review the progress made to \n commercialize SDC as a food safety solution.\n \n \n The Participant Dial-In Number for the conference call is \n 1-631-891-4304. Participants should dial in to the call at least five \n minutes before 1:30pm PDT (4:30pm EDT) on June 8, 2017. The call can \n also be accessed “live” online at http://public.viavid.com/index.php?id=123679.\n \n \n A replay of the webcast will be available on the Company’s website (http://www.purebio.com/about/investor_relations). \n A replay of the conference call will be available by dialing \n 1-844-512-2921 (international participants dial 1-412-317-6671) starting \n June 8, 2017, at 7:30pm EDT through June 15, 2017 at 11:59 pm EDT. \n Please use PIN Number 10002719.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety arena -- \n providing solutions to the health and environmental challenges of \n pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic \n antimicrobial agent, which offers 24-hour residual protection and \n formulates well with other compounds. As a platform technology, SDC is \n distinguished from existing products in the marketplace because of its \n superior efficacy, reduced toxicity and it mitigates bacterial \n resistance. PURE is headquartered in El Cajon, California (San Diego \n metropolitan area). Additional information on PURE is available at www.purebio.com.\n \n \n Forward-looking Statements\n \n \n Any statements contained in this press release that do not describe \n historical facts may constitute forward-looking statements as that term \n is defined in the Private Securities Litigation Reform...